The global sore throat lozenges market is estimated to be valued at US$ 4.4 billion in 2024. The market is expected to expand at a CAGR rate of 5.6% and reach a valuation of ~US$ 7.5 billion by 2034.
| Data Points | Market Insights |
|---|---|
| Sore Throat Lozenges Market Value, 2023 | US$ 4.1 billion |
| Estimated Market Value 2024 | US$ 4.4 billion |
| Projected Market Value 2034 | US$ 7.5 billion |
| Valued-based CAGR (2024 to 2034) | 5.6% |
| Market Share of Top 5 Countries | 57.1% |
Around the world, the common cold and cough are very frequent. Consequently, there is a constant need for therapies and medications to treat it. This fuels the demand for throat lozenges often referred to as cough sweets, cough drops, cachous, or troches, which are small, medicinal pills that are frequently used as the first line of treatment against the common cold and flu.
The thin, moist mucosa that lines the throat is susceptible to invasion by bacteria and viruses. This causes inflammation, which manifests as redness, swelling, and increased secretions. The demand for lozenges is increasing for treatment of infection as they contain active components, such as antiseptics, painkillers, menthol, eucalyptus oil, cough suppressants like dextromethorphan, and calming substances.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The sale of sore throat lozenges market expanded at a CAGR of 4.9% during the historical period, owing to a rise in over-the-counter (OTC) medications, especially for common cold and flu remedies.
| Attribute | Details |
|---|---|
| HCAGR (2019 to 2023) | 4.9% |
The market for sore throat lozenges is expected to rise over the forecast period. This is because of the increase in demand for these decongestants due to increasing cases of nasal and throat infections, especially during seasonal changes. Children are at higher risk of acquiring infections, and they prefer these lozenges over any other second line of treatments available.
Additionally, throat lozenges are used as the initial course of treatment for sore throats, colds, and flu. Moreover, among all flu strains, the common cold is the one that individuals tend to cure at home rather than constantly seeking medical attention. This is one of the reasons for the growth of the market for sore throat lozenges. The global market for sore throat lozenges is anticipated to exhibit a CAGR of 5.6% during the forecast period.
The aging population's decreased immunity can increase the frequency of catching colds and other diseases with sore throats as a symptom. This is expected to generate opportunities in the market. More throat decongestants in the form of lozenges, which quickly relieve symptoms, are highly recommended.
Since ancient times, lozenges have been used to treat throat infections. To improve the effectiveness of the throat lozenge's activities, a small amount of heroin and morphine are also added. The newest addition to the decongestant medications for sore throat is zinc lozenges. In underdeveloped nations, zinc deficiency is common. Within 48 hours of the onset of symptoms, zinc lozenges are commonly given every 2 to 3 hours to treat the common cold.
Sore throat lozenges provide momentary or symptomatic relief to patients suffering from extreme pain caused by severe infection. Moreover, continuous advancements and new product announcements enriched with natural herbs and components are projected to support growth in the market. Accessibility is a significant aspect that can propel the market's expansion. Almost all neighborhood pharmacies and local drug stores sell these throat decongestants over the counter. Due to this, the industry is expected to grow at a profit in the upcoming years.
Principal Consultant
The sore throat lozenges market is expected to show attractive growth over the coming years. The global throat lozenges industry is quite saturated due to the presence of several local and international businesses offering wide varieties of cough and cold relief products in the market. While some organizations have implemented strategic approaches like acquisition and strategic alliance for market expansion, the majority of businesses are concentrating on affordable treatment. These throat lozenges must be taken several times during the day to provide temporary comfort.
Menthol-containing lozenges may make the situation worse rather than better, depending on how they are made. Additionally, it may occasionally trigger hypersensitivity reactions in those who are allergic to the content. It may also lead to irritable larynx syndrome. Some studies indicate that these OTC first-line drugs, which just provide symptomatic relief, may even make the situation worse; as a result, they should only be taken cautiously and when necessary.
| Country/Region | CAGR (2024 to 2034) |
|---|---|
| United Kingdom | 5.4% |
| Germany | 5.2% |
| Japan | 4.6% |
| China | 6.6% |
Due to the numerous awareness campaigns aimed at reducing infectious diseases in the area as well as the existence of several big throat lozenge manufacturers, the market is expected to grow at a CAGR of 5.4% over the forecast period. The country’s cold climate promotes the growth of bacteria that cause throat infections and also boosts the market there.
The region’s high proportion of elderly people and the effects of the cold climate drive the expansion of the market in Japan. The market in Japan is expected to grow at a CAGR of 4.6% during the forecast period.
Germany accounted for around 27.4% of Europe’s market in 2023. The market is Germany in expected to grow at a CAGR of 5.2% through 2034. Factors such increased number of top pharmaceutical manufacturers in Germany account for this high market demand in the sore throat lozenges market.
The market in China is expected to register a CAGR of 6.6% over the forecast period. The increase in the number of children and the elderly population susceptible to developing a throat infection is surging the demand for throat lozenges, propelling the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Top Product Type | Hard Candy Lozenges |
|---|---|
| Market Share in 2024 | 46.5% |
The demand for hard candy lozenges is projected to showcase significant growth during the specified period. This segment holds a substantial share of 46.5% of the market by product. These hard candy lozenges are more common and contribute more to the market, owing to their popularity and easy availability.
| Top Type | OTC Medication |
|---|---|
| Market Share in 2024 | 85.3% |
OTC type of medication for common flu and pharyngitis is highly preferred for sore throat lozenges type and it holds a maximum share of 85.3% of the market by type. Due to their availability in the market and in all medicine stores, over-the-counter medications are highly preferred by consumers.
| Top Distribution Channel | Retail Pharmacies |
|---|---|
| Market Share in 2024 | 36.7% |
Retail Pharmacies facilitate sales of the product worth US$ 1.5 billion and hold a share of 36.7% of the market by distribution channel. The easy availability of throat lozenges in the local drug stores and their OTC prescriptions drive the demand for lozenges.
The market for sore throat lozenges is characterized by the presence of experienced competitors. These companies are focused on making decongestants easily accessible to the general public in large quantities. Key strategies employed by companies in the sore throat lozenges industry include new product innovation, launches, obtaining regulatory approvals, and expanding their operations. These strategies enable them to stay competitive and meet the evolving needs of consumers.
Recent Developments
| Attribute | Details |
|---|---|
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | US$ billion for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, Russia, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, Israel, North Africa, and South Africa |
| Key Market Segments Covered | Product, Type, Distribution Channel, and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The sore throat lozenges market is worth US$ 4.4 billion in 2024 and is set to expand 1.7X over the next ten years.
The sore throat lozenges market is expected to reach US$ 7.5 billion by the end of 2034.
The global market is expected to expand at a CAGR of 5.6% through 2034 due to the rising geriatric population and increased cases of common cold and throat infections.
The United States, China, Japan, Germany, and India are the top 5 countries that are driving the demand for sore throat lozenges.
North America is one of the key markets for sore throat lozenges, with the U.S. accounting for about 92.7% of the North American sore throat lozenges market.
Demand for sore throat lozenges in Europe is expected to register a growth of 5.1% over the next ten years.
South Asia’s market in sore throat lozenges is offering lucrative growth opportunities and is expected to exhibit healthy growth of 6.7% CAGR during the forecast period.
iNova Pharmaceuticals, Procter & Gamble (P&G) Company, Reckitt Benckiser Group Plc, Ricola AG, and Mondelēz International., are some of the key players in the sore throat lozenges industry.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Market Round Offs
1.5. FMI Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion & Exclusion
3. Brand Mapping Analysis
3.1. Price v/s Product
3.2. Value for Money
3.3. Top of Mind Organic Cosmetics Brands
3.4. Brand Portfolio-by Key Players
3.5. Brand Loyalty Mapping
3.6. Usage Pattern Overview
3.7. Branded vs Unbranded-Market Mix
4. Distribution Channel Wise Key Brand Positioning
4.1. Global Top Retailers and their Brand Offerings
4.1.1. Supermarkets/Hypermarkets (Key Brands)
4.1.2. Department Stores (Key Brands)
4.1.3. Specialty Stores (Key Brands)
4.1.4. Mono Brand Stores (Key Brands)
4.1.5. Online (Key Brands)
4.2. Retail Pricing Strategies
5. Consumer Buying Behavior Analysis
5.1. Functionality and Product Demand
5.1.1. Skin & Sun Care
5.1.2. Hair Care
5.1.3. Bath & Shower
5.1.4. Men’s Grooming ( only shaving )
5.1.5. Color Cosmetic
5.1.6. Fragrance & Deodorants
5.1.7. Oral Care
5.2. What factors do you consider when deciding to purchase Organic Cosmetic over conventional cosmetics?
5.3. How important are product certifications (e.g. USDA organic, Ecocert, etc.) when choosing Organic Cosmetic products?
5.4. What type of packaging do you prefer for Organic Cosmetic products?
5.5. How important is brand reputation and recognition when selecting Ingredients Cosmetic products?
5.6. What marketing channels do you prefer for learning about new Ingredients Cosmetic products?
5.7. How important is the ingredient list when selecting Ingredients Cosmetic products?
5.8. What types of natural ingredients are you most interested in seeing in your cosmetics products?
5.9. How often do you purchase new natural cosmetic products?
5.9.1. Once or More Every Month
5.9.2. Once Every 2 months
5.9.3. Once Every 6 Months
5.9.4. Once a Year
5.9.5. Less Than Once A Year
6. Market Trends & Dynamics
6.1. Per capita spending on organic & natural cosmetic products
6.2. Key Trends Impacting the Market
6.3. Product Innovation / Development Trends
6.3.1. Latest Trends and Demands
6.3.2. Latest Innovations and New Launches
6.4. Future Prospects of Organic Cosmetics Industry
6.5. Market Dynamics
6.5.1. Drivers
6.5.2. Restraints
6.5.3. Opportunity Analysis
7. Value Added Insights
7.1. Product Adoption / Usage Analysis
7.2. New Product Launches
7.3. Investment Feasibility Matrix
7.4. PESTEL Analysis
7.5. Porter’s Five Force Analysis
7.6. Value Chain Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Global Healthcare Expenditure Outlook
8.1.3. Global Life Expectancy Outlook
8.1.4. R&D Funding by Region
8.1.5. Digital Health Funding
8.1.6. Geriatric Population
8.2. Forecast Factors - Relevance & Impact
8.2.1. Product Adoption / Analysis Rules
8.2.2. New Product Development & Applications
8.2.3. Key Player’s Historic Growth
8.2.4. Lifestyle Changes & Health Awareness
8.2.5. Market Consolidation Activities
8.2.6. Increasing Demand of Digital Scales
8.2.7. New Innovations in Scales
8.2.8. Expansion into Emerging Markets
9. Global Market Demand (in Value or Size in US$ Million) Analysis 2018 to 2023 and Forecast, 2024 to 2034
9.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
9.2. Historical Market Value (US$ Million) Analysis, 2018 to 2023
9.3. Current and Future Market Value (US$ Million) Projections, 2024 to 2034
9.3.1. Y-o-Y Growth Trend Analysis
9.3.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis, By Product, 2018 to 2023
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2024 to 2034
10.3.1. Hard candy lozenges
10.3.2. Soft lozenges
10.3.3. Compressed lozenges
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Type
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis, By Type, 2018 to 2023
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Type, 2024 to 2034
11.3.1. OTC
11.3.2. Prescription
11.4. Market Attractiveness Analysis By Type
12. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Distribution Channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis, By Distribution Channel, 2018 to 2023
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2024 to 2034
12.3.1. Hospital
12.3.2. Retail Pharmacies
12.3.3. Drug stores
12.3.4. Online pharmacies
12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis, By Region, 2018 to 2023
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2024 to 2034
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East & Africa
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2018 to 2023
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024 to 2034
14.3.1. By Country
14.3.1.1. USA
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Type
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Type
14.4.4. By Distribution Channel
14.5. Market Trends
14.6. Market Drivers & Restraints – Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. USA Market
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Product
14.7.1.2.2. By Type
14.7.1.2.3. By Distribution Channel
14.7.2. Canada Market
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Product
14.7.2.2.2. By Type
14.7.2.2.3. By Distribution Channel
15. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2018 to 2023
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024 to 2034
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of LATAM
15.3.2. By Product
15.3.3. By Type
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Type
15.4.4. By Distribution Channel
15.5. Market Trends
15.6. Market Drivers & Restraints – Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. Brazil Market
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Product
15.7.1.2.2. By Type
15.7.1.2.3. By Distribution Channel
15.7.2. Mexico Market
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Product
15.7.2.2.2. By Type
15.7.2.2.3. By Distribution Channel
15.7.3. Argentina Market
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Product
15.7.3.2.2. By Type
15.7.3.2.3. By Distribution Channel
16. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2018 to 2023
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024 to 2034
16.3.1. By Country
16.3.1.1. UK
16.3.1.2. Germany
16.3.1.3. France
16.3.1.4. Italy
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Type
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Type
16.4.4. By Distribution Channel
16.5. Market Trends
16.6. Market Drivers & Restraints – Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. UK Market
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Product
16.7.1.2.2. By Type
16.7.1.2.3. By Distribution Channel
16.7.2. Germany Market
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Product
16.7.2.2.2. By Type
16.7.2.2.3. By Distribution Channel
16.7.3. France Market
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast by Market Taxonomy
16.7.3.2.1. By Product
16.7.3.2.2. By Type
16.7.3.2.3. By Distribution Channel
16.7.4. Italy Market
16.7.4.1. Introduction
16.7.4.2. Market Analysis and Forecast by Market Taxonomy
16.7.4.2.1. By Product
16.7.4.2.2. By Type
16.7.4.2.3. By Distribution Channel
16.7.5. Spain Market
16.7.5.1. Introduction
16.7.5.2. Market Analysis and Forecast by Market Taxonomy
16.7.5.2.1. By Product
16.7.5.2.2. By Type
16.7.5.2.3. By Distribution Channel
16.7.6. BENELUX Market
16.7.6.1. Introduction
16.7.6.2. Market Analysis and Forecast by Market Taxonomy
16.7.6.2.1. By Product
16.7.6.2.2. By Type
16.7.6.2.3. By Distribution Channel
16.7.7. Russia Market
16.7.7.1. Introduction
16.7.7.2. Market Analysis and Forecast by Market Taxonomy
16.7.7.2.1. By Product
16.7.7.2.2. By Type
16.7.7.2.3. By Distribution Channel
17. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2018 to 2023
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024 to 2034
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Type
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. BY Country
17.4.2. By Product
17.4.3. By Type
17.4.4. By Distribution Channel
17.5. Market Trends
17.6. Market Drivers & Restraints – Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. China Market
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Product
17.7.1.2.2. By Type
17.7.1.2.3. By Distribution Channel
17.7.2. Japan Market
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Product
17.7.2.2.2. By Type
17.7.2.2.3. By Distribution Channel
17.7.3. South Korea Market
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Product
17.7.3.2.2. By Type
17.7.3.2.3. By Distribution Channel
18. South Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
18.1. Introduction
18.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2018 to 2023
18.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024 to 2034
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Indonesia
18.3.1.3. Thailand
18.3.1.4. Malaysia
18.3.1.5. Rest of South Asia
18.3.2. By Product
18.3.3. By Type
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Type
18.4.4. By Distribution Channel
18.5. Market Trends
18.6. Market Drivers & Restraints – Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. India Market
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Product
18.7.1.2.2. By Type
18.7.1.2.3. By Distribution Channel
18.7.2. Indonesia Market
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. By Product
18.7.2.2.2. By Type
18.7.2.2.3. By Distribution Channel
18.7.3. Thailand Market
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast by Market Taxonomy
18.7.3.2.1. By Product
18.7.3.2.2. By Type
18.7.3.2.3. By Distribution Channel
18.7.4. Malaysia Market
18.7.4.1. Introduction
18.7.4.2. Market Analysis and Forecast by Market Taxonomy
18.7.4.2.1. By Product
18.7.4.2.2. By Type
18.7.4.2.3. By Distribution Channel
19. Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
19.1. Introduction
19.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2018 to 2023
19.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024 to 2034
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Type
19.3.4. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Type
19.4.4. By Distribution Channel
19.5. Market Trends
19.6. Market Drivers & Restraints – Impact Analysis
19.7. Country Level Analysis & Forecast
19.7.1. Australia Market
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast by Market Taxonomy
19.7.1.2.1. By Product
19.7.1.2.2. By Type
19.7.1.2.3. By Distribution Channel
19.7.2. New Zealand Market
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast by Market Taxonomy
19.7.2.2.1. By Product
19.7.2.2.2. By Type
19.7.2.2.3. By Distribution Channel
20. Middle East & Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
20.1. Introduction
20.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2018 to 2023
20.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024 to 2034
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Türkiye
20.3.1.3. South Africa
20.3.1.4. North Africa
20.3.1.5. Rest of MEA
20.3.2. By Product
20.3.3. By Type
20.3.4. By Distribution Channel
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Type
20.4.4. By Distribution Channel
20.5. Market Trends
20.6. Market Drivers & Restraints – Impact Analysis
20.7. Country Level Analysis & Forecast
20.7.1. GCC Countries Market
20.7.1.1. Introduction
20.7.1.2. Market Analysis and Forecast by Market Taxonomy
20.7.1.2.1. By Product
20.7.1.2.2. By Type
20.7.1.2.3. By Distribution Channel
20.7.2. Türkiye Market
20.7.2.1. Introduction
20.7.2.2. Market Analysis and Forecast by Market Taxonomy
20.7.2.2.1. By Product
20.7.2.2.2. By Type
20.7.2.2.3. By Distribution Channel
20.7.3. South Africa Market
20.7.3.1. Introduction
20.7.3.2. Market Analysis and Forecast by Market Taxonomy
20.7.3.2.1. By Product
20.7.3.2.2. By Type
20.7.3.2.3. By Distribution Channel
20.7.4. North Africa Market
20.7.4.1. Introduction
20.7.4.2. Market Analysis and Forecast by Market Taxonomy
20.7.4.2.1. By Product
20.7.4.2.2. By Type
20.7.4.2.3. By Distribution Channel
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Concentration
22. Competition Analysis
22.1. Competition Dashboard
22.2. Branding and Promotional Strategies, By key Players
22.3. Key Development Analysis
22.4. Competition Deep Dive
22.4.1. iNova
22.4.1.1. Overview
22.4.1.2. Product Portfolio
22.4.1.3. Key Financials
22.4.1.4. SWOT Analysis
22.4.1.5. Key Developments
22.4.1.6. Sales Footprint
22.4.1.7. Strategy Overview
22.4.1.7.1. Marketing Strategy
22.4.1.7.2. Product Strategy
22.4.1.7.3. Channel Strategy
22.4.2. Procter & Gamble (P&G) Company
22.4.3. Reckitt Benckiser Group Plc
22.4.4. Ricola AG
22.4.5. Mondelēz International.
22.4.6. Thornton & Ross Ltd.
22.4.7. Traditional Medicinals, Inc.
22.4.8. Bliss GVS Pharma Ltd.
22.4.9. GlaxoSmithKline Plc
22.4.10. Honibe
22.4.11. SSL International
22.4.12. Cipla Ltd
22.4.13. Novartis
22.4.14. Johnson & Johnson
22.4.15. Other Players (As Requested)
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Food and Beverage Insights
View Reports
Sore Throat Lozenges Market
